News

MySize Unveils NaizGPT: The Future of Retail AI Interactions

MySize Unveils NaizGPT: The Future of Retail AI Interactions

MySize Introduces NaizGPT

MySize Inc., a pioneering company in AI-driven retail solutions, has proudly launched NaizGPT, an innovative conversational AI designed to redefine how retail teams interact with data. This groundbreaking tool allows e-commerce professionals to engage with their data through natural conversations instead of the conventional method of sifting through dashboards.

Transforming Data Interaction in Retail

What if retail teams could simply ask questions and receive data-driven insights instantaneously? With NaizGPT, this is no longer a futuristic dream but a current reality. Powered by a retail-optimized large language model, this assistant enables users to explore complex datasets and gain insights with fewer hurdles, thus enhancing decision-making processes.

Initial Feedback and Successful Pilot Phase

Currently, NaizGPT is in the pilot stage, being trialed by selected teams within the Naiz Fit platform. Early feedback indicates remarkable engagement among users, demonstrating its utility in facilitating deep data analysis through conversational queries. Retail teams can ask specific questions, such as:

Examples of Questions Retail Teams Can Ask

Some of the insightful inquiries that users can pose include:

  • "What was my most returned category this month?"
  • "Why are blazers being returned - is it a specific item or the entire category?"
  • "Is this jacket running larger than other items in the blazer category?"
  • "What are customers saying when they return this specific item?"

Intuitive Insights at Your Fingertips

NaizGPT utilizes rich data from MySize’s sizing recommendation engine, covering a range of interactions from size recommendations to user purchases and returns. By translating this comprehensive data into conversational formats, the AI offers contextual insights, which elevate the understanding of consumer behavior and product performance. This shift towards conversational analytics is deemed crucial for future retail strategies.

CEO Insights on NaizGPT Impact

Ronen Luzon, CEO of MySize, noted, "We're seeing teams ask follow-up questions they never thought to ask before. Instead of looking at a return rate number, they are having a conversation with their data to understand the 'why' behind every metric. NaizGPT validates our vision that the future of retail analytics is conversational, not dashboard-based."

Next Steps: Integrating Feedback into Development

This pilot phase marks a vital step in MySize’s overarching ambition to make NaizGPT the central conversational AI interface for all retail operations. Following the invaluable feedback gathered during the pilot, MySize plans to enhance and evolve the assistant. Future updates will integrate advanced technologies, expand data sources, and cater to teams across merchandising, marketing, and inventory functions.

Looking Ahead: Commercial Availability Timeline

MySize aims to transition NaizGPT from its pilot stage to commercial availability in the upcoming quarters. The long-term vision is to establish a leading conversational AI platform within the retail sector, empowering teams to easily converse with their data and secure immediate actionable insights.

About MySize Inc.

MySize, Inc. (NASDAQ: MYSZ) stands at the forefront of AI-driven size recommendation and digital commerce solutions in the fashion industry. With notable offerings like MySizeID and Naiz Fit, and an entry into the circular fashion realm through Percentil, MySize is dedicated to helping retailers enhance fit, minimize returns, and elevate the overall shopping experience, both online and offline.

Contact Information

For further inquiries or to arrange a demonstration, reach out to:

Oren Elmaliah, CFO
Email: ir@mysizeide.com
Website: https://mysizeid.com

Frequently Asked Questions

What is NaizGPT?

NaizGPT is a conversational AI tool launched by MySize Inc. that enables retail teams to interact with complex data through natural language.

How does NaizGPT benefit e-commerce teams?

This AI provides insights quickly and intuitively, allowing teams to ask detailed questions and gain data-driven answers seamlessly.

What are some example queries for NaizGPT?

Teams can ask questions about return rates, sizing accuracy, and customer feedback on specific items.

What is the long-term vision for NaizGPT?

MySize intends to make NaizGPT the leading conversational AI platform for retail, enhancing its capabilities and integrating wider data sources.

Where can I find more information about MySize?

Additional information can be found on MySize’s official website: www.mysizeid.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 5

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 8

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 6

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Solar Insure Launches Innovative 30-Year Battery Warranty

Updated Category News Views 464

Solar Insure Introduces a New Battery Warranty Solar Insure is making a significant stride in the renewable energy sector with the introduction of the SI-30 Battery Warranty. This new warranty, featuring an impressive 30-year protection plan, is designed to give homeowners and solar providers peace of mind regarding their energy storage solutions. As battery storage...

Continue Reading
Opendoor's Road Ahead: Analysis of Settlement and Strategies

Updated Category News Views 175

Understanding Opendoor's Recent Settlement Opendoor Technologies (NASDAQ: OPEN) recently found itself in the spotlight due to a $39 million settlement aimed at resolving a federal class action lawsuit. This lawsuit stemmed from allegations that Opendoor misrepresented the effectiveness of its home-pricing algorithms, claiming to have improved automation when, in reality,...

Continue Reading
Scandinavian Tobacco Group Expands Share Buy-Back Program

Updated Category News Views 78

Scandinavian Tobacco Group Enhances Shareholder Value Scandinavian Tobacco Group A/S has recently taken significant steps to bolster its capital structure through a well-planned share buy-back program. This initiative aims to enhance shareholder value and support the management of obligations related to the company’s employee share-based incentive programs. Overview of...

Continue Reading
Akebia's Strategic Shift in Kidney Disease Drug Development

Updated Category News Views 205

The Shift in Akebia Therapeutics' Approach Akebia Therapeutics Inc. (NASDAQ: AKBA) has made headlines recently as its stock experienced a decline in value. This downward trend coincided with important discussions held between the company and the U.S. Food and Drug Administration (FDA) regarding its pivotal trial design for vadadustat, intended to treat anemia in patients...

Continue Reading
Fall Fun and Creativity at Art Ave in the Golden Triangle

Updated Category News Views 237

Art Ave Launches Exciting Fall Activities In the bustling heart of downtown, a new wave of creativity is set to unfold. This fall, the Golden Triangle Business Improvement District (BID) is thrilled to present Art Ave, an exhilarating outdoor initiative designed to connect the White House and Dupont Circle through vibrant public art and enriched community engagement....

Continue Reading